Ultragenyx Net Income from 2010 to 2026

RARE Stock  USD 20.52  2.98  12.68%   
Ultragenyx's Net Loss is decreasing over the years with slightly volatile fluctuation. Overall, Net Loss is projected to go to about -546.2 M this year. During the period from 2010 to 2026 Ultragenyx Net Loss annual values regression line had coefficient of variation of (81.08) and r-squared of  0.85. View All Fundamentals
 
Net Loss  
First Reported
2011-12-31
Previous Quarter
-115 M
Current Value
-129 M
Quarterly Volatility
60 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 42.9 M, Interest Expense of 65.1 M or Selling General Administrative of 388.3 M, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.0028 or PTB Ratio of 16.57. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
  
Build AI portfolio with Ultragenyx Stock
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
Analyzing Ultragenyx's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Ultragenyx's current valuation and future prospects.

Latest Ultragenyx's Net Income Growth Pattern

Below is the plot of the Net Income of Ultragenyx over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Ultragenyx financial statement analysis. It represents the amount of money remaining after all of Ultragenyx operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Ultragenyx's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ultragenyx's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (569.18 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Ultragenyx Net Income Regression Statistics

Arithmetic Mean(297,879,824)
Coefficient Of Variation(81.08)
Mean Deviation209,452,401
Median(245,874,000)
Standard Deviation241,516,847
Sample Variance58330.4T
Range700.6M
R-Value(0.92)
Mean Square Error9484.3T
R-Squared0.85
Slope(44,031,551)
Total Sum of Squares933286.2T

Ultragenyx Net Income History

2026-546.2 M
2025-575 M
2024-569.2 M
2023-606.6 M
2022-707.4 M
2021-454 M
2020-186.6 M

Other Fundumenentals of Ultragenyx

Ultragenyx Net Income component correlations

About Ultragenyx Financial Statements

Ultragenyx stakeholders use historical fundamental indicators, such as Ultragenyx's Net Income, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ultragenyx's assets and liabilities are reflected in the revenues and expenses on Ultragenyx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-512.3 M-486.7 M
Net Loss-512.3 M-537.9 M
Net Loss-636.7 M-604.8 M
Net Loss(5.83)(6.12)
Net Income Per E B T 1.01  0.80 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Will Biotechnology sector continue expanding? Could Ultragenyx diversify its offerings? Factors like these will boost the valuation of Ultragenyx. Anticipated expansion of Ultragenyx directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ultragenyx data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.83)
Revenue Per Share
6.826
Quarterly Revenue Growth
0.255
Return On Assets
(0.25)
Return On Equity
(4.13)
Understanding Ultragenyx requires distinguishing between market price and book value, where the latter reflects Ultragenyx's accounting equity. The concept of intrinsic value - what Ultragenyx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Ultragenyx's price substantially above or below its fundamental value.
It's important to distinguish between Ultragenyx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ultragenyx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ultragenyx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.